Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Jing Tan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Health and Quality of Life Outcomes|June 3, 2026
Updated algorithms for direct and indirect mapping of WHOQOL-BREF to EQ-5D-5L utility scores using data from a multi-provincial Thai general population sampleKrittaphas Kangwanrattanakul, Yi Jing Tan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart FailureYi Jing Tan, Siew Chin Ong
Value in Health Regional Issues|March 27, 2026
Assessment of Quality of Life Among Chronic Heart Failure Outpatients in Malaysia: Propensity Score Matched Analysis Between Self- and Proxy-Reports in 6 Health DimensionsYi Jing Tan, Siew Chin Ong
Plos One|August 23, 2024
Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fractionYi Jing Tan, Stephan Linden, Siew Chin Ong
Clinical Therapeutics|September 11, 2024
Budget Impact Analysis of Dapagliflozin in Treating Patients With Heart Failure With Reduced Ejection Fraction From the Perspective of Malaysian Public Healthcare SystemYi Jing Tan, Joo Zheng Low, Siew Chin Ong
Applied Health Economics and Health Policy|August 30, 2023
Is Using Sodium-Glucose Cotransporter-2 Inhibitors to Treat Adults with Chronic Heart Failure Cost-Effective? A Systematic Review of Cost-Effectiveness StudiesYi Jing Tan, Siew Chin Ong, Ying Min Kan
Journal of Pharmaceutical Policy and Practice|January 25, 2022
Improving bedside dispensing services through early medication discharge planning: a pre-post intervention studyAi Ling Oh, Yi Jing Tan, Wan Choon Chong, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 5, 2024
Examining health-related quality of life in ambulatory adult patients with chronic heart failure: insights from Malaysia using EQ-5D-5LYi Jing Tan, Siew Chin Ong, Vee Sim Yong, et al.
Journal of Patient-Reported Outcomes|July 25, 2024
Translation, cross-cultural adaptation, and psychometric validation of the Malay version of the Assessment of Quality of Life-6 Dimensions (Malay-AQoL-6D) instrument among Malaysians living with chronic heart failureYi Jing Tan, Siew Chin Ong, Sook Pin Goh, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Health and Quality of Life Outcomes|June 3, 2026
Updated algorithms for direct and indirect mapping of WHOQOL-BREF to EQ-5D-5L utility scores using data from a multi-provincial Thai general population sampleKrittaphas Kangwanrattanakul, Yi Jing Tan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart FailureYi Jing Tan, Siew Chin Ong
Value in Health Regional Issues|March 27, 2026
Assessment of Quality of Life Among Chronic Heart Failure Outpatients in Malaysia: Propensity Score Matched Analysis Between Self- and Proxy-Reports in 6 Health DimensionsYi Jing Tan, Siew Chin Ong
Plos One|August 23, 2024
Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fractionYi Jing Tan, Stephan Linden, Siew Chin Ong
Clinical Therapeutics|September 11, 2024
Budget Impact Analysis of Dapagliflozin in Treating Patients With Heart Failure With Reduced Ejection Fraction From the Perspective of Malaysian Public Healthcare SystemYi Jing Tan, Joo Zheng Low, Siew Chin Ong
Applied Health Economics and Health Policy|August 30, 2023
Is Using Sodium-Glucose Cotransporter-2 Inhibitors to Treat Adults with Chronic Heart Failure Cost-Effective? A Systematic Review of Cost-Effectiveness StudiesYi Jing Tan, Siew Chin Ong, Ying Min Kan
Journal of Pharmaceutical Policy and Practice|January 25, 2022
Improving bedside dispensing services through early medication discharge planning: a pre-post intervention studyAi Ling Oh, Yi Jing Tan, Wan Choon Chong, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 5, 2024
Examining health-related quality of life in ambulatory adult patients with chronic heart failure: insights from Malaysia using EQ-5D-5LYi Jing Tan, Siew Chin Ong, Vee Sim Yong, et al.
Journal of Patient-Reported Outcomes|July 25, 2024
Translation, cross-cultural adaptation, and psychometric validation of the Malay version of the Assessment of Quality of Life-6 Dimensions (Malay-AQoL-6D) instrument among Malaysians living with chronic heart failureYi Jing Tan, Siew Chin Ong, Sook Pin Goh, et al.
Pageof 1